Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:27 Feb 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1238.90 [ +4.75% ]TCS 2489.85 [ +0.32% ]

Sensex28812.88
-80.09 -0.28%

Nifty8896.70
-42.80 -0.48%

Midcap13533.78
1.67 0.01%

Smallcap13609.88
22.10 0.16%


Bse Corporate Announcements Back
Taro gets final approval for the Imiquimod cream Sun Pharmaceuticals Industries has 48.7% stake, and
Taro gets final approval for the Imiquimod cream Sun Pharmaceuticals Industries has 48.7% stake, and 65.8% Voting rights in Taro Pharmaceuticals. Taro Pharmaceuticals has received final approval for Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (FDA) for Imiquimod cream 5%. It was originally developed and marketed by Graceway Pharmaceuticals under the brand name cream Aldara 5%. It is indicated for the treatment of actinic Keratosis and external genital warts. It has approximate annual sales of USD 340 million in the US market. Sun Pharmaceuticals Industries has 48.7% stake, and 65.8% Voting rights in Taro Pharmaceuticals.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com